| FXO | IAK | FXO / IAK | |
| Gain YTD | 10.814 | 6.812 | 159% |
| Net Assets | 2.14B | 634M | 338% |
| Total Expense Ratio | 0.61 | 0.38 | 161% |
| Turnover | 75.00 | 12.00 | 625% |
| Yield | 1.86 | 1.87 | 99% |
| Fund Existence | 19 years | 20 years | - |
| FXO | IAK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 88% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 87% |
| Advances ODDS (%) | 2 days ago 85% | 2 days ago 85% |
| Declines ODDS (%) | 10 days ago 80% | 17 days ago 74% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 65% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JXI | 81.52 | 0.54 | +0.67% |
| iShares Global Utilities ETF | |||
| RSMR | 21.65 | 0.02 | +0.08% |
| FT Vest U.S. Equity Equal Weight Buffer ETF - March | |||
| SDIV | 24.34 | 0.01 | +0.04% |
| Global X SuperDividend™ ETF | |||
| JANT | 40.38 | N/A | +0.01% |
| AllianzIM US Large Cap Buffer10 Jan ETF | |||
| THNR | 24.46 | N/A | N/A |
| Amplify Weight Loss Drug & Treatment ETF | |||
A.I.dvisor indicates that over the last year, FXO has been closely correlated with HBAN. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if FXO jumps, then HBAN could also see price increases.
A.I.dvisor indicates that over the last year, IAK has been closely correlated with HIG. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if IAK jumps, then HIG could also see price increases.